Merkel Cell Carcinoma
Showing 9976 - 10000 of >10,000
Following Treatment With Fate Therapeutics' Engineered Cellular
Terminated
- Hematological Malignancy
- Genetically engineered NK cells
-
Phoenix, Arizona
- +4 more
Aug 24, 2022
Heart Transplant Rejection Trial in Helsinki (Cell-free DNA)
Recruiting
- Heart Transplant Rejection
- Cell-free DNA
-
Helsinki, Uusimaa, FinlandHelsinki University Hospital
Oct 2, 2023
Knee Osteoarthritis Trial in Rosario (Measuring synovial fluid components)
Active, not recruiting
- Knee Osteoarthritis
- Measuring synovial fluid components
-
Rosario, Santa Fe, ArgentinaDharma Centro de Medicina Regenerativa
Jul 26, 2022
Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage IIIB, Non Small Cell Lung Cancer Metastatic Trial in Southampton
Unknown status
- Non Small Cell Lung Cancer
- +2 more
- Exercise
-
Southampton, United KingdomUniversity Hospitals Southampton NHS Foundation Trust
Jul 4, 2019
B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,
Active, not recruiting
- B-Lymphoid Malignancies
- +3 more
- Fludarabine
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 1, 2022
Non-Small Cell Lung Carcinoma Trial in Guangdong (IMRT, WBRT, erlotinib)
Terminated
- Non-Small Cell Lung Carcinoma
- IMRT
- +2 more
-
Guangdong, ChinaHui Liu
Apr 10, 2019
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial (Cyclophosphamide, Vincristine, Dexamethasone)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
- (no location specified)
Aug 2, 2022
Immune Checkpoint Inhibitor, Lung Cancer, Liver Biomarkers Trial in Amiens (Blood sample)
Recruiting
- Immune Checkpoint Inhibitor
- +3 more
- Blood sample
-
Amiens, FranceCHU Amiens
Dec 8, 2022
Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer Trial in Canada, Poland, United States
Recruiting
- Ovarian Granulosa-Stromal Tumor
- +2 more
-
Los Angeles, California
- +20 more
Jul 13, 2022
LONGitudinal Multi-omics Phenotyping of KIDney Function
Not yet recruiting
- Chronic Kidney Diseases
-
Berlin, GermanyExperimental and Clinical Research Center
Oct 4, 2022
FDG-PET/CT Imaging as Early Predictor of DP
Completed
- Lymphoma
- There is no intervention
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 7, 2022
Lactate Blood Increase, Thiamine Deficiency Trial in Charleroi (Thiamine 500 MG, Placebo)
Completed
- Lactate Blood Increase
- Thiamine Deficiency
- Thiamine 500 MG
- Placebo
-
Charleroi, Hainaut, BelgiumCHU-Charleroi Hopital Civil Marie Curie
Nov 16, 2022
Spread of Colorectal Carcinomatosis
Completed
- Peritoneal Carcinomatosis
- Sampling peritoneal tissue
-
Ghent, BelgiumGhent University Hospital
Dec 9, 2022
Oncology Research Information Exchange Network Lung Cancer Study
Active, not recruiting
- Lung Cancer
- Non-small Cell Lung Cancer
- No Intervention
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 30, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Transgender Persons Trial in San Antonio (Botnia Clamp, Withdrawal of Gender Affirming Hormone Therapy (GAHT))
Recruiting
- Transgender Persons
- Botnia Clamp
- Withdrawal of Gender Affirming Hormone Therapy (GAHT)
-
San Antonio, TexasBartter Clinical Research Unit, Audie L. Murphy VA Hospital, sTX
Jan 18, 2022
AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)
Recruiting
- AML, Adult
- CLL1 CAR-NK cell injection
-
Hangzhou, Zhejiang, ChinaClinical research ethics committee of the first affiliated hospi
Aug 30, 2023
Advanced Kidney Cancer Trial in Tianjin (Pembrolizumab plus Lenvatinib)
Recruiting
- Advanced Kidney Cancer
- Pembrolizumab plus Lenvatinib
-
Tianjin, Tianjin, ChinaChangyi Quan
Aug 4, 2022
COVID-19 Trial (Recombinant two-component COVID-19 vaccine (CHO cell), Placebo)
Not yet recruiting
- COVID-19
- Recombinant two-component COVID-19 vaccine (CHO cell)
- Placebo
- (no location specified)
Aug 1, 2022
Stem Cell Transplantation, Hematologic Malignancy Trial in Washington, Chicago, Hackensack (Expressive Helping, Factual Writing)
Active, not recruiting
- Stem Cell Transplantation
- Hematologic Malignancy
- Expressive Helping
- Factual Writing
-
Washington, District of Columbia
- +2 more
Jun 9, 2022
CD20+ Aggressive B-Cell Lymphoma Trial in Germany (Conventional Vincristine, Liposomal Vincristine, Ricover-scheme rituximab)
Active, not recruiting
- CD20+ Aggressive B-Cell Lymphoma
- Conventional Vincristine
- +3 more
-
Homburg, Saarland, Germany
- +125 more
Nov 11, 2022
Pneumonia Post Haematopoietic Stem Cell Transplantation
Completed
- Pneumonia
- Hematopoietic Stem Cell Transplantation
-
Guangzhou, Guangdong, ChinaGuangzhou Women and Children's Medical Center
Nov 22, 2021
Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)
Recruiting
- Ewing's Family Tumors
- +11 more
- Ifosfamide
- +13 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Nasopharyngeal Carcinoma, Nutritional Support Trial in China (dietary supplement, radiation, drug)
Recruiting
- Nasopharyngeal Carcinoma
- Nutritional Support
- Abbott®Ensure
- +2 more
-
Fuzhou, Fujian, China
- +12 more
May 16, 2022
Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)
Withdrawn
- Leukemia
- Stem Cell Transplantation
-
Munich, Bavaria, Germany3. Medizinische Klinik, Klinikum rechts der Isar der TU München
Dec 5, 2022